Free Trial

KalVista Pharmaceuticals (KALV) Short Interest Ratio & Short Volume

KalVista Pharmaceuticals logo
$13.28 -0.23 (-1.70%)
As of 01:03 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

KalVista Pharmaceuticals Short Interest Data

KalVista Pharmaceuticals (KALV) has a short interest of 10.06 million shares, representing 22.50% of the float (the number of shares available for trading by the public). This marks a 8.76% increase in short interest from the previous month. The short interest ratio (days to cover) is 8.7, indicating that it would take 8.7 days of the average trading volume of 774,154 shares to cover all short positions.

Current Short Interest
10,060,000 shares
Previous Short Interest
9,250,000 shares
Change Vs. Previous Month
+8.76%
Dollar Volume Sold Short
$137.12 million
Short Interest Ratio
8.7 Days to Cover
Last Record Date
July 31, 2025
Outstanding Shares
50,340,000 shares
Short Percent of Float
22.50%
Today's Trading Volume
172,876 shares
Average Trading Volume
774,154 shares
Today's Volume Vs. Average
22%
Short Selling KalVista Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for KalVista Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

KALV Short Interest Over Time

KALV Days to Cover Over Time

KALV Percentage of Float Shorted Over Time

KalVista Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/202510,060,000 shares $137.12 million +8.8%22.5%8.7 $13.63
7/15/20259,250,000 shares $140.32 million +8.8%N/A8.5 $15.17
6/30/20258,500,000 shares $96.14 million +36.0%19.1%8.5 $11.31
6/15/20256,250,000 shares $81 million +0.5%14.0%8.5 $12.96
5/31/20256,220,000 shares $73.15 million +1.8%14.1%10.5 $11.76
5/15/20256,110,000 shares $71.24 million +4.3%13.8%10 $11.66
4/30/20255,860,000 shares $80.69 million -5.6%N/A9.9 $13.77
4/15/20256,210,000 shares $74.64 million +6.0%14.0%11.2 $12.02
3/31/20255,860,000 shares $67.62 million +0.3%13.2%11.2 $11.54
3/15/20255,840,000 shares $73.58 million +5.4%13.2%12.9 $12.60
2/28/20255,540,000 shares $63.16 million -5.0%12.5%13.3 $11.40
2/15/20255,830,000 shares $56.90 million -18.2%13.2%15.7 $9.76
1/31/20257,130,000 shares $63.53 million -6.1%N/A19.3 $8.91
1/15/20257,590,000 shares $59.66 million +1.9%N/A21 $7.86
12/31/20247,450,000 shares $63.10 million +3.8%N/A21.5 $8.47
12/15/20247,180,000 shares $62.39 million -1.1%N/A17.8 $8.69
11/30/20247,260,000 shares $73.04 million -1.5%N/A17.6 $10.06
11/15/20247,370,000 shares $69.94 million +7.3%N/A17.7 $9.49
10/31/20246,870,000 shares $70.55 million +0.9%N/A19 $10.27
10/15/20246,810,000 shares $81.58 million +4.6%N/A20.1 $11.98
9/30/20246,510,000 shares $75.39 million +13.8%N/A17 $11.58
9/15/20245,720,000 shares $63.72 million +1.2%N/A15.6 $11.14
8/31/20245,650,000 shares $75.65 million -0.5%N/A17.4 $13.39
8/15/20245,680,000 shares $72.65 million -5.0%N/A17.9 $12.79
7/31/20245,980,000 shares $86.95 million -5.5%N/A18.3 $14.54
7/15/20246,330,000 shares $94.70 million +7.7%N/A18.4 $14.96
6/30/20245,880,000 shares $69.27 million +4.3%N/A17.7 $11.78
6/15/20245,640,000 shares $68.07 million +2.2%N/A15.4 $12.07
5/31/20245,520,000 shares $64.42 million -4.2%N/A14.1 $11.67
5/15/20245,760,000 shares $69.18 million +4.0%N/A11.7 $12.01
4/30/20245,540,000 shares $62.88 million -4.8%N/A7.4 $11.35
4/15/20245,820,000 shares $68.33 million +5.4%N/A7.3 $11.74
3/31/20245,520,000 shares $65.47 million +12.2%N/A6.8 $11.86
3/15/20244,920,000 shares $58.70 million +9.1%N/A6.4 $11.93
2/29/20244,510,000 shares $61.56 million +50.8%18.6%5.9 $13.65
2/15/20242,990,000 shares $44.13 million +21.1%12.4%4.4 $14.76
1/31/20242,470,000 shares $38.95 million -10.5%12.9%6.1 $15.77
1/15/20242,760,000 shares $35.77 million -25.2%14.2%8.3 $12.96
12/31/20233,690,000 shares $45.20 million +5.7%18.7%11.8 $12.25
12/15/20233,490,000 shares $37.27 million -9.6%16.7%10.8 $10.68
He Called Nvidia at $1.10. Now, He Says THIS Stock Will… (Ad)

The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.tc pixel

See his full breakdown of the seven stocks to own now
11/30/20233,860,000 shares $32.58 million -3.5%18.2%13.4 $8.44
11/15/20234,000,000 shares $30.76 million -3.4%19.0%13.9 $7.69
10/31/20234,140,000 shares $35.15 million -10.8%17.3%14.8 $8.49
10/15/20234,640,000 shares $42.13 million +4.7%N/A16.9 $9.08
9/30/20234,430,000 shares $42.66 million +9.1%N/A16.9 $9.63
9/15/20234,060,000 shares $39.87 million +4.6%N/A19.4 $9.82
8/31/20233,880,000 shares $42.10 million -5.4%N/A19.1 $10.85
8/15/20234,100,000 shares $44.32 million +2.8%19.7%21.4 $10.81
7/31/20233,990,000 shares $40.30 million +2.3%18.3%21 $10.10
7/15/20233,900,000 shares $37.60 million +3.7%17.9%21 $9.64
6/30/20233,760,000 shares $33.84 million +0.8%17.3%18.5 $9.00
6/15/20233,730,000 shares $35.92 million +3.9%17.2%17.2 $9.63
5/31/20233,590,000 shares $35.00 million +5.0%16.5%14.6 $9.75
5/15/20233,420,000 shares $34.58 million +4.3%15.8%12.6 $10.11
4/30/20233,280,000 shares $27.98 million +17.1%14.0%11.5 $8.53
4/15/20232,800,000 shares $22.15 million +3.3%12.0%8.7 $7.91
3/31/20232,710,000 shares $21.30 million +10.2%11.6%8 $7.86
3/15/20232,460,000 shares $18.33 million +13.4%N/A7 $7.45
2/28/20232,170,000 shares $15.91 million -19.6%N/A6.3 $7.33
2/15/20232,700,000 shares $20.87 million -0.4%N/A8.6 $7.73
1/31/20232,710,000 shares $21.57 million +26.6%N/A8.9 $7.96
1/15/20232,140,000 shares $15.19 million -10.5%N/A6.7 $7.10
12/30/20222,390,000 shares $16.16 million +14.9%10.2%7.4 $6.76
12/15/20222,080,000 shares $11.90 million No Change10.4%4.7 $5.72
11/30/20222,080,000 shares $11.21 million No Change10.4%5.1 $5.39
11/15/20222,080,000 shares $10.86 million -8.8%10.4%5.1 $5.22
10/31/20222,280,000 shares $11.56 million -0.4%10.9%5.5 $5.07
10/15/20222,290,000 shares $10.44 million -10.2%10.9%6.2 $4.56
9/30/20222,550,000 shares $37.00 million +3.7%12.2%7.7 $14.51
9/15/20222,460,000 shares $36.43 million +4.7%11.8%13.2 $14.81
8/31/20222,350,000 shares $38.70 million +14.6%11.2%10.7 $16.47
8/15/20222,050,000 shares $32.41 million +8.5%9.8%7.3 $15.81
7/31/20221,890,000 shares $23.34 million +2.7%9.0%6.1 $12.35
7/15/20221,840,000 shares $22.69 million +3.4%8.7%5.7 $12.33
6/30/20221,780,000 shares $17.52 million -16.8%8.5%5.3 $9.84
6/15/20222,140,000 shares $19.07 million +58.5%10.2%6.4 $8.91
5/31/20221,350,000 shares $12.00 million +7.1%6.4%4.6 $8.89
5/15/20221,260,000 shares $12.23 million +37.7%6.0%5.4 $9.71
4/30/2022914,800 shares $11.65 million +4.6%4.3%4.4 $12.73
4/15/2022874,800 shares $12.56 million -19.7%4.2%4.2 $14.36
3/31/20221,090,000 shares $16.07 million -17.4%5.2%5.2 $14.74
3/15/20221,320,000 shares $19.14 million +1.5%6.3%6.6 $14.50
2/28/20221,300,000 shares $20.87 million +13.0%6.2%6.3 $16.05
2/15/20221,150,000 shares $18.95 million -5.7%5.5%5 $16.48
1/31/20221,220,000 shares $15.40 million +15.1%5.8%5.7 $12.62
1/15/20221,060,000 shares $13.29 million +11.9%5.0%5 $12.54
12/31/2021947,400 shares $12.53 million +0.4%4.5%4.7 $13.23
12/15/2021943,800 shares $12.81 million -2.2%4.2%4.4 $13.57
11/30/2021964,800 shares $13.99 million -6.3%4.3%4.4 $14.50
11/15/20211,030,000 shares $17.94 million -5.5%4.6%5.4 $17.42
He Called Nvidia at $1.10. Now, He Says THIS Stock Will… (Ad)

The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvidia at $1.10 reveals AI’s Next Magnificent Seven… including one stock he says could become America’s next trillion-dollar giant.tc pixel

See his full breakdown of the seven stocks to own now
10/29/20211,090,000 shares $19.60 million -11.4%4.9%5.8 $17.98
10/15/20211,230,000 shares $21.17 million +3.4%5.5%6.9 $17.21
9/30/20211,190,000 shares $20.77 million -14.4%5.4%6.5 $17.45
9/15/20211,390,000 shares $26.76 million -21.0%6.2%7 $19.25
8/31/20211,760,000 shares $35.97 million -4.9%7.9%8.7 $20.44
8/13/20211,850,000 shares $35.72 million -4.2%8.3%8.6 $19.31
7/30/20211,930,000 shares $38.87 million -1.5%9.5%8.5 $20.14
7/15/20211,960,000 shares $43.04 million -2.0%9.9%7.7 $21.96
6/30/20212,000,000 shares $47.92 million +39.9%10.1%6.7 $23.96
6/15/20211,430,000 shares $40.78 million +3.6%7.2%4.6 $28.52
5/28/20211,380,000 shares $37.26 million -3.5%7.0%4.2 $27.00
5/14/20211,430,000 shares $35.91 million +6.7%N/A3.9 $25.11
4/30/20211,340,000 shares $33.81 million +3.1%N/A1.2 $25.23
4/15/20211,300,000 shares $32.40 million +10.2%N/A1.2 $24.92
3/31/20211,180,000 shares $30.33 million +51.8%N/A1.2 $25.70
3/15/2021777,400 shares $25.27 million -0.6%N/A0.8 $32.50
2/26/2021782,400 shares $25.99 million +22.0%N/A0.9 $33.22
2/12/2021641,100 shares $25.93 million +25.0%3.8%0.7 $40.45
1/29/2021513,100 shares $8.02 million +28.2%4.5%0.8 $15.64
1/15/2021400,200 shares $6.88 million +4.7%3.5%3.3 $17.18
12/31/2020382,400 shares $7.22 million +27.3%3.4%3.2 $18.89
12/15/2020300,300 shares $5.69 million -11.6%2.7%3 $18.95
11/30/2020339,700 shares $6.61 million +3.9%3.0%3.8 $19.47
11/15/2020326,900 shares $6.15 million +47.0%2.8%3.8 $18.80
10/30/2020222,400 shares $3.83 million -12.3%1.9%2.9 $17.22
10/15/2020253,600 shares $3.79 million +2.3%2.2%3.7 $14.95
9/30/2020247,900 shares $3.12 million -16.4%2.1%3.8 $12.59
9/15/2020296,600 shares $4.12 million -7.1%2.5%3.4 $13.88
8/31/2020319,100 shares $4.18 million -10.6%2.7%2.6 $13.10

KALV Short Interest - Frequently Asked Questions

What is KalVista Pharmaceuticals' current short interest?

Short interest is the volume of KalVista Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of July 31st, investors have sold 10,060,000 shares of KALV short. 22.50% of KalVista Pharmaceuticals' shares are currently sold short. Learn More on KalVista Pharmaceuticals' current short interest.

What is a good short interest ratio for KalVista Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KALV shares currently have a short interest ratio of 9.0. Learn More on KalVista Pharmaceuticals's short interest ratio.

Which institutional investors are shorting KalVista Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of KalVista Pharmaceuticals: Walleye Capital LLC, and Simplex Trading LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for KalVista Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 22.50% of KalVista Pharmaceuticals' floating shares are currently sold short.

Is KalVista Pharmaceuticals' short interest increasing or decreasing?

KalVista Pharmaceuticals saw a increase in short interest during the month of July. As of July 31st, there was short interest totaling 10,060,000 shares, an increase of 8.8% from the previous total of 9,250,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does KalVista Pharmaceuticals' short interest compare to its competitors?

22.50% of KalVista Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to KalVista Pharmaceuticals: Recursion Pharmaceuticals, Inc. (35.39%), Catalyst Pharmaceuticals, Inc. (8.42%), Kiniksa Pharmaceuticals International, plc (7.05%), Organon & Co. (5.79%), Alvotech (1.02%), Centessa Pharmaceuticals PLC Sponsored ADR (5.10%), ImmunityBio, Inc. (35.13%), Tarsus Pharmaceuticals, Inc. (21.18%), Ocular Therapeutix, Inc. (7.55%), Agios Pharmaceuticals, Inc. (7.38%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks.

What does it mean to sell short KalVista Pharmaceuticals stock?

Short selling KALV is an investing strategy that aims to generate trading profit from KalVista Pharmaceuticals as its price is falling. KALV shares are trading down $0.23 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against KalVista Pharmaceuticals?

A short squeeze for KalVista Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of KALV, which in turn drives the price of the stock up even further.

How often is KalVista Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KALV, twice per month. The most recent reporting period available is July, 31 2025.




This page (NASDAQ:KALV) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners